Results 281 to 290 of about 80,532 (301)

‘Off-the-shelf’ allogeneic CAR T cells: development and challenges

Nature Reviews Drug Discovery, 2020
Stéphane Depil, Laurent Poirot
exaly  

Navigating CAR-T cells through the solid-tumour microenvironment

Nature Reviews Drug Discovery, 2021
Andrew J Hou, Laurence C Chen, Yvonne Y Chen   +2 more
exaly  

Depletion of BATF in CAR-T cells enhances antitumor activity by inducing resistance against exhaustion and formation of central memory cells

Cancer Cell, 2022
Haoyi Wang, Chenze Zhang
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Beyond the storm — subacute toxicities and late effects in children receiving CAR T cells

Nature Reviews Clinical Oncology, 2021
Haneen Shalabi, Juliane Gust, Rebecca A Gardner   +2 more
exaly  

CAR-NK cells for haematological cancers

Best Practice & Research Clinical Haematology
Mohammadamin Noorafrooz, Robert Peter Gale, Ramin Noorafrooz, Sanaz Ghods   +3 more
openaire   +1 more source

Engineering CAR-T Cells for Next-Generation Cancer Therapy

Cancer Cell, 2020
Mihe Hong, Justin Clubb, Yvonne Y Chen
exaly  

Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours

Nature Reviews Clinical Oncology, 2022
Christian Luca Flugel, Robbie G Majzner, Giedre Krenciute   +2 more
exaly  

Will allogeneic CAR T cells for CD19+ malignancies take autologous CAR T cells ‘off the shelf’?

Nature Reviews Clinical Oncology, 2021
Amanda M Dinofia, Stephan A Grupp
exaly  

Promising early results with CAR NK cells

Nature Reviews Clinical Oncology
openaire   +2 more sources